| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 80.6 | ¤9,171 | CN |
| 000999.CN | China Resources Sanjiu Medical & Pharmac | 67.3 | ¤7,817 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 74.9 | ¤5,538 | CN |
| 300832.CN | Shenzhen New Industries Biomedical Engin | 61.1 | ¤5,524 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 83.2 | ¤5,499 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 301580.CN | Aidite (Qinhuangdao) Technology Co., Ltd | 69.5 | ¤510 | CN |
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 56.3 | ¤569 | CN |
| 688253.CN | Innovita Biological Technology Co., Ltd. | 61.8 | ¤613 | CN |
| 603439.CN | GuiZhou SanLi Pharmaceutical Co., Ltd. C | 73.5 | ¤706 | CN |
| 688581.CN | Hangzhou AGS MedTech Co. Ltd. | 70.5 | ¤709 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 000999.CN | China Resources Sanjiu Medical & Pharmac | 67.3 | 18 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 80.6 | 18 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 74.9 | 17 | CN |
| 600566.CN | HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Cl | 65.3 | 16 | CN |
| 300529.CN | Jafron Biomedical Co., Ltd. Class A | 51.3 | 8 | CN |
| 600216.CN | Zhejiang Medicine Co., Ltd. Class A | 68.4 | 8 | CN |
| 600285.CN | Henan Lingrui Pharmaceutial Co., Ltd. Cl | 65.9 | 7 | CN |
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 56.3 | 6 | CN |
| 600779.CN | Sichuan Swellfun Co., Ltd. Class A | 70.7 | 6 | CN |
| 300705.CN | Hunan Jiudian Pharmaceutical Co. Ltd. Cl | 74.4 | 5 | CN |
| Average Market Cap | ¤2,605 |
| Median Market Cap | ¤1,737 |
| Avg. 3 Mo. Dollar Vol. | ¤28,936,670 |
| Avg. 3 Mo. Trading Vol. | 7,514,132 |
| Last Rebalance Date | 12/16/2024 |
| Companies Replaced | 11 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 18.3 |
| Forward P/E Ratio (12 Mo.) | 16.2 |
| Price/Book Ratio | 3.4 |
| Avg. Revenue Chg. - 3 Yr | 64.2% |
| Avg. Op. Income Chg. - 3 Yr. | 87.8% |
| Avg. EPS Growth - 3 Yr. | 21.6% |
| Avg. EPS Growth - 1 Yr. | 27.0% |
| Avg. Operating Margin | 27.5% |
| Avg. LT Debt to Total Capital | 10.2% |
| Avg. Return on Equity | 18.4% |
| Dividend Yield | 1.6% |
| China Health Care Index | 68.42 |
| China | 100.0% |
